trending Market Intelligence /marketintelligence/en/news-insights/trending/uxi4zqohrrstp-b-iixgra2 content esgSubNav
In This List

Factor Therapeutics director retires

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Factor Therapeutics director retires

Factor Therapeutics Ltd. said Robert Ryan retired from the board.

Ryan joined the board as a nonexecutive director in September 2016. He is president and CEO of Innova Therapeutics.

Darra, Australia-based Factor Therapeutics is a clinical-stage biotechnology company that develops and commercializes treatments for wound care and healing.